Terminal Disclaimers, ODP, and PTA: What Patent Teams Should Review
A professional checklist for reviewing terminal disclaimer and obviousness-type double patenting risk across patent families.
Terminal disclaimers are easy to file and hard to ignore later. They can affect patent term, enforcement posture, family strategy, ownership alignment, and diligence review.
For experienced patent teams, terminal disclaimer review should be part of portfolio hygiene.
Start With the Family Tree
Obviousness-type double patenting is a family problem. Review continuations, divisionals, CIPs, shared inventorship, common ownership, joint research agreements, and claim overlap.
The key question is not only whether a terminal disclaimer was filed. It is what patent it ties to, what claims drove the issue, and whether later family members create new risk.
Review PTA and Expiration
Patent term adjustment can make ODP analysis more consequential. If one family member has substantial PTA, a later ODP issue may affect expected term value. Practitioners should compare expiration dates with and without PTA and review whether terminal disclaimers already limit term.
USPTO materials on disclaimers note that terminal disclaimers may affect PTA under 35 U.S.C. 154(b). Official procedural treatment is addressed in MPEP 1490.
Do Not Treat Ownership as a Formality
Terminal disclaimers can require common ownership or enforcement conditions. In diligence, licensing, or corporate restructuring, confirm that ownership and enforcement rights still line up with the disclaimer obligations.
This is especially important across subsidiaries, joint ventures, acquisitions, and divested portfolios.
Compare Claims, Not Just Titles
ODP risk lives in claim scope. Two patents with similar titles may claim different inventions. Two patents with different titles may have overlapping claims. Use claim charts or side-by-side claim review to understand the actual overlap.
Patent Bear's family, priority, claim, and chart workflows can help surface where claim overlap and term issues deserve attorney review.
Keep a Portfolio-Level Record
Terminal disclaimer decisions should be traceable. Capture the rejection, the reference patent, the claims at issue, the filed disclaimer, and the resulting term effect.
That record matters later when the portfolio is asserted, licensed, sold, financed, or challenged.
Review family overlap and term clues
Use Patent Bear family, priority, and claim views to find where ODP and PTA issues deserve closer review.